Your browser doesn't support javascript.
loading
Expected endpoints from future chikungunya vaccine trial sites informed by serological data and modeling.
Tran, Quan Minh; Soda, James; Siraj, Amir; Moore, Sean; Clapham, Hannah; Alex Perkins, T.
Afiliação
  • Tran QM; Department of Biological Sciences and Eck Institute for Global Health, University of Notre Dame, United States. Electronic address: qtran4@nd.edu.
  • Soda J; Department of Biological Sciences and Eck Institute for Global Health, University of Notre Dame, United States.
  • Siraj A; Department of Biological Sciences and Eck Institute for Global Health, University of Notre Dame, United States.
  • Moore S; Department of Biological Sciences and Eck Institute for Global Health, University of Notre Dame, United States.
  • Clapham H; Saw Swee Hock School of Public Health, National University of Singapore, Singapore.
  • Alex Perkins T; Department of Biological Sciences and Eck Institute for Global Health, University of Notre Dame, United States.
Vaccine ; 41(1): 182-192, 2023 01 04.
Article em En | MEDLINE | ID: mdl-36424258
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / Febre de Chikungunya Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / Febre de Chikungunya Idioma: En Ano de publicação: 2023 Tipo de documento: Article